Edition:
United States

Trinity Biotech PLC (TRIB.OQ)

TRIB.OQ on NASDAQ Stock Exchange Global Select Market

6.81USD
2 Dec 2016
Change (% chg)

$-0.04 (-0.58%)
Prev Close
$6.85
Open
$6.81
Day's High
$6.88
Day's Low
$6.79
Volume
75,792
Avg. Vol
40,163
52-wk High
$13.65
52-wk Low
$5.76

TRIB.OQ

Chart for TRIB.OQ

About

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the... (more)

Overall

Beta: 1.18
Market Cap(Mil.): $161.97
Shares Outstanding(Mil.): 23.96
Dividend: 0.22
Yield (%): 3.25

Financials

  TRIB.OQ Industry Sector
P/E (TTM): 11.45 29.13 29.87
EPS (TTM): 0.59 -- --
ROI: 4.68 15.56 14.95
ROE: 7.62 16.69 16.29

BRIEF-Stonepine Capital LP reports 6.2 pct passive stake in Trinity Biotech

* Stonepine Capital LP reports 6.2 percent passive stake in Trinity Biotech Plc as of October 14 - sec filing Source text : http://bit.ly/2f1bxvS Further company coverage:

Nov 02 2016

BRIEF-Trinity Biotech announces withdrawal of Troponin FDA 510(k) submission

* Trinity biotech announces withdrawal of Troponin FDA 510(k) submission

Oct 04 2016

Competitors

Earnings vs. Estimates